Genes have become the preferred way to explain all types ofill health and unwanted behavior. Some of the attributions seemfairly clear-cut, but many are being embraced uncritically andoversold. This situation can be troubling for clinicians, aswell as for the general public. It is often hard to be surethat genes do account for someone's complex condition, suchas circulatory problems or cancer. But even when such an associationseems fairly clear, it is hard to know what practical conclusionsto draw. Unfortunately, many of these uncertainties arise fromthe way genes function, not just from shortcomings . . . [Full Text of this Article]
References
Related Letters:
Pitfalls of Genetic Testing
Stern H. J., Maddalena A., Schulman J. D., Foulkes W. D., Bunn H. F., Stossel T. P., Forget B. G., Stamatoyannopoulos G., Weatherall D. J., Hubbard R., Lewontin R.C.
Extract |
Full Text
N Engl J Med 1996;
335:1235-1237, Oct 17, 1996.
Correspondence
This article has been cited by other articles:
Parthasarathy, S.
(2005). Architectures of Genetic Medicine: Comparing Genetic Testing for Breast Cancer in the USA and the UK. Social Studies of Science
35: 5-40
[Abstract]
Daly, P. A., Nolan, C., Green, A., Ormiston, W., Cody, N., McDevitt, T., O'hIci, B., Byrne, D., McDermott, E., Carney, D. N., O'Higgins, N., Barton, D. E.
(2003). Predictive testing for BRCA1 and 2 mutations: a male contribution. Ann Oncol
14: 549-553
[Abstract][Full Text]
Burke, W.
(2002). Genetic Testing. NEJM
347: 1867-1875
[Full Text]
Aktan-Collan, K., Haukkala, A., Mecklin, J.-P., Uutela, A., Kaariainen, H.
(2001). Comprehension of cancer risk one and 12 months after predictive genetic testing for hereditary non-polyposis colorectal cancer. J. Med. Genet.
38: 787-792
[Full Text]
Peshkin, B. N., DeMarco, T. A., Brogan, B. M., Lerman, C., Isaacs, C.
(2001). BRCA1/2 Testing: Complex Themes in Result Interpretation. JCO
19: 2555-2565
[Abstract][Full Text]
Ashburn, T. T., Wilson, S. K., Eisenstein, B. I.
(2000). Human Tissue Research in the Genomic Era of Medicine: Balancing Individual and Societal Interests. Arch Intern Med
160: 3377-3384
[Abstract][Full Text]
Bogardus, S. T. Jr, Concato, J., Feinstein, A. R.
(1999). Clinical Epidemiological Quality in Molecular Genetic Research: The Need for Methodological Standards. JAMA
281: 1919-1926
[Abstract][Full Text]
Cogswell, M. E., McDonnell, S. M., Khoury, M. J., Franks, A. L., Burke, W., Brittenham, G.
(1998). Iron Overload, Public Health, and Genetics: Evaluating the Evidence for Hemochromatosis Screening. ANN INTERN MED
129: 971-979
[Abstract][Full Text]
Newman, B., Mu, H., Butler, L. M., Millikan, R. C., Moorman, P. G., King, M.-C.
(1998). Frequency of Breast Cancer Attributable to BRCA1 in a Population-Based Series of American Women. JAMA
279: 915-921
[Abstract][Full Text]
Gill, M., Richards, T.
(1998). Meeting the challenge of genetic advance. BMJ
316: 570-570
[Full Text]
Kodish, E.
(1997). Commentary: Risks and Benefits, Testing and Screening, Cancer, Genes and Dollars. J Law Med Ethics
25: 252-255
Ponder, B.
(1997). Genetic Testing for Cancer Risk. Science
278: 1050-1054
[Abstract][Full Text]
Struewing, J. P., Hartge, P., Wacholder, S., Baker, S. M., Berlin, M., McAdams, M., Timmerman, M. M., Brody, L. C., Tucker, M. A.
(1997). The Risk of Cancer Associated with Specific Mutations of BRCA1 and BRCA2 among Ashkenazi Jews. NEJM
336: 1401-1408
[Abstract][Full Text]
Giardiello, F. M., Brensinger, J. D., Petersen, G. M., Luce, M. C., Hylind, L. M., Bacon, J. A., Booker, S. V., Parker, R. D., Hamilton, S. R.
(1997). The Use and Interpretation of Commercial APC Gene Testing for Familial Adenomatous Polyposis. NEJM
336: 823-827
[Abstract][Full Text]
Stern, H. J., Maddalena, A., Schulman, J. D., Foulkes, W. D., Bunn, H. F., Stossel, T. P., Forget, B. G., Stamatoyannopoulos, G., Weatherall, D. J., Hubbard, R., Lewontin, R.C.
(1996). Pitfalls of Genetic Testing. NEJM
335: 1235-1237
[Full Text]